2. Stanghellini V, Cogliandro RF, de Giorgio R, Barbara G, Salvioli B, Corinaldesi R. 2007; Chronic intestinal pseudo-obstruction: manifestations, natural history and management. Neurogastroenterol Motil. 19:440–452. DOI:
10.1111/j.1365-2982.2007.00902.x. PMID:
17564625.
Article
3. Vanek VW, Al-Salti M. 1986; Acute pseudo-obstruction of the colon (Ogilvie's syndrome). An analysis of 400 cases. Dis Colon Rectum. 29:203–210. DOI:
10.1007/BF02555027. PMID:
3753674.
4. Delmer A, Cymbalista F, Bauduer F, et al. 1995; Acute colonic pseudo-obstruction (Ogilvie's syndrome) during induction treatment with chemotherapy and all-trans-retinoic acid for acute promyelocytic leukemia. Am J Hematol. 49:97–98. DOI:
10.1002/ajh.2830490120. PMID:
7741149.
Article
5. Xie H, Peereboom DM. 2012; Ogilvie's syndrome during chemotherapy with high-dose methotrexate for primary CNS lymphoma. J Clin Oncol. 30:e192–e194. DOI:
10.1200/JCO.2011.40.6801. PMID:
22711852.
Article
6. Johnston G, Vitikainen K, Knight R, Annest L, Garcia C. 1992; Changing perspective on gastrointestinal complications in patients undergoing cardiac surgery. Am J Surg. 163:525–529. DOI:
10.1016/0002-9610(92)90402-D. PMID:
1575312.
Article
7. Sreter KB, Barisic B, Popovic-Grle S. 2017; Pharmacogenomics and tailored polypharmacy: an 80-year-old lady with rosuvastatin-associated rhabdomyolysis and maprotiline-related Ogilvie's syndrome. Int J Clin Pharmacol Ther. 55:442–448. DOI:
10.5414/CP202784. PMID:
28257284.
Article
8. De Giorgio R, Barbara G, Stanghellini V, et al. 2001; Review article: the pharmacological treatment of acute colonic pseudo-obstruction. Aliment Pharmacol Ther. 15:1717–1727. DOI:
10.1046/j.1365-2036.2001.01088.x. PMID:
11683685.
11. Stübner S, Rustenbeck E, Grohmann R, et al. 2004; Severe and uncommon involuntary movement disorders due to psychotropic drugs. Pharmacopsychiatry. 37 Suppl 1:S54–S64. DOI:
10.1055/s-2004-815511. PMID:
15052515.
Article
14. de Bruin GJ, Bac DJ, van Puijenbroek EP, van der Klooster JM. 2009; Ogilvie syndrome induced by clozapine. Ned Tijdschr Geneeskd. 153:B437. PMID:
20051163.
15. Pelizza L, De Luca P, La Pesa M, Borella D. 2007; Clozapine-induced intestinal occlusion: a serious side effect. Acta Biomed. 78:144–148. PMID:
17933283.
18. Gurrera RJ, Caroff SN, Cohen A, et al. 2011; An international consensus study of neuroleptic malignant syndrome diagnostic criteria using the Delphi method. J Clin Psychiatry. 72:1222–1228. DOI:
10.4088/JCP.10m06438. PMID:
21733489.
Article